AAAAAA
Results: 1-25/47
Authors:
Alberts, DS
Hallum, AV
Stratton-Custis, M
Garcia, DJ
Gleason-Guzman, M
Salmon, SE
Santabarbara, P
Niesor, EJ
Floret, S
Bentzen, CL
Citation: Ds. Alberts et al., Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of apomine (SR-45023A), a novel oral biphosphonate anticancer drug, CLIN CANC R, 7(5), 2001, pp. 1246-1250
Authors:
Chow, HHS
Cai, Y
Alberts, DS
Hakim, I
Dorr, R
Shahi, F
Crowell, JA
Yang, CS
Hara, Y
Citation: Hhs. Chow et al., Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E, CANC EPID B, 10(1), 2001, pp. 53-58
Authors:
Waltmire, CN
Alberts, DS
Dorr, RT
Citation: Cn. Waltmire et al., Sequence-dependent cytotoxicity of combination chemotherapy using paclitaxel, carboplatin and bleomycin in human lung and ovarian cancer, ANTI-CANC D, 12(7), 2001, pp. 595-602
Authors:
Dorr, RT
Liddil, JD
Sami, SM
Remers, W
Hersh, EM
Alberts, DS
Citation: Rt. Dorr et al., Preclinical antitumor activity of the azonafide series of anthracene-basedDNA intercalators, ANTI-CANC D, 12(3), 2001, pp. 213-220
Authors:
Alberts, DS
Citation: Ds. Alberts, Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer? The Markman article reviewed, ONCOLOGY-NY, 15(1), 2001, pp. 103-104
Authors:
Bozzo, P
Alberts, DS
Vaught, L
da Silva, VD
Thompson, D
Warnecke, J
Miller, RC
Einspahr, J
Bartels, PH
Citation: P. Bozzo et al., Measurement of chemopreventive efficacy in skin biopsies, ANAL QUAN C, 23(4), 2001, pp. 300-312
Authors:
Garcia, FAR
Davis, JR
Alberts, DS
Hatch, K
Weyn, B
Thompson, D
Bartels, PH
Citation: Far. Garcia et al., Nuclear chromatin patterns in normal, hyperplastic and atypical endometrium, ANAL QUAN C, 23(2), 2001, pp. 144-150
Authors:
Bartels, PH
Garcia, FAR
Davis, J
da Silva, VD
Bartels, HG
Thompson, D
Alberts, DS
Citation: Ph. Bartels et al., Progression curves for endometrial lesions, ANAL QUAN C, 23(1), 2001, pp. 1-8
Authors:
Markman, M
Bundy, BN
Alberts, DS
Fowler, JM
Clark-Pearson, DL
Carson, LF
Wadler, S
Sickel, J
Citation: M. Markman et al., Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel andintraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group, J CL ONCOL, 19(4), 2001, pp. 1001-1007
Authors:
Rothenberg, ML
Liu, PY
Wilczynski, S
Hannigan, EV
Weiner, SA
Weiss, GR
Hunter, VJ
Chapman, JA
Tiersten, A
Kohler, PC
Alberts, DS
Citation: Ml. Rothenberg et al., Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: A Southwest Oncology Group trial (SWOG-9326), GYNECOL ONC, 82(2), 2001, pp. 317-322
Authors:
Foote, JA
Harris, RB
Giuliano, AR
Roe, DJ
Moon, TE
Cartmel, B
Alberts, DS
Citation: Ja. Foote et al., Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults, INT J CANC, 95(1), 2001, pp. 7-11
Authors:
Maltzman, T
Knoll, K
Martinez, ME
Byers, T
Stevens, BR
Marshall, JR
Reid, ME
Einspahr, J
Hart, N
Bhattacharyya, AK
Kramer, CB
Sampliner, R
Alberts, DS
Ahnen, DJ
Citation: T. Maltzman et al., Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: Relationship to histologic and clinical characteristics, GASTROENTY, 121(2), 2001, pp. 302-309
Authors:
Martinez, ME
Sampliner, R
Marshall, JR
Bhattacharyya, AK
Reid, ME
Alberts, DS
Citation: Me. Martinez et al., Adenoma characteristics as risk factors for recurrence of advanced adenomas, GASTROENTY, 120(5), 2001, pp. 1077-1083
Authors:
Xu, XC
Wong, WYL
Goldberg, L
Baer, SC
Wolf, JE
Ramsdell, WM
Alberts, DS
Lippman, SM
Lotan, R
Citation: Xc. Xu et al., Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis, CANCER RES, 61(11), 2001, pp. 4306-4310
Authors:
Samimi, G
Fink, D
Varki, NM
Husain, A
Hoskins, WJ
Alberts, DS
Howell, SB
Citation: G. Samimi et al., Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy, CLIN CANC R, 6(4), 2000, pp. 1415-1421
Authors:
Chow, HHS
Earnest, DL
Clark, D
Mason-Liddil, N
Kramer, CB
Einspahr, JG
Guillen-Rodriguez, JM
Roe, DJ
Malone, W
Crowell, JA
Alberts, DS
Citation: Hhs. Chow et al., Effect of subacute ibuprofen dosing on rectal mucosal prostaglandin E-2 levels in healthy subjects with a history of resected polyps, CANC EPID B, 9(4), 2000, pp. 351-356
Authors:
Alberts, DS
Dorr, RT
Einspahr, JG
Aickin, M
Saboda, K
Xu, MJ
Peng, YM
Goldman, R
Foote, JA
Warneke, JA
Salasche, S
Roe, DJ
Bowden, GT
Citation: Ds. Alberts et al., Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine, CANC EPID B, 9(12), 2000, pp. 1281-1286
Authors:
Calaluce, R
Earnest, DL
Heddens, D
Einspahr, JG
Roe, D
Bogert, CL
Marshall, JR
Alberts, DS
Citation: R. Calaluce et al., Effects of piroxicam on prostaglandin E-2 levels in rectal mucosa of adenomatous polyp patients: A randomized phase IIb trial, CANC EPID B, 9(12), 2000, pp. 1287-1292
Authors:
Simon, R
Desper, R
Papadimitriou, CH
Peng, A
Alberts, DS
Taetle, R
Trent, JM
Schaffer, AA
Citation: R. Simon et al., Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis, GENE CHROM, 28(1), 2000, pp. 106-120
Authors:
Stratton, SP
Dorr, RT
Alberts, DS
Citation: Sp. Stratton et al., The state-of-the-art in chemoprevention of skin cancer, EUR J CANC, 36(10), 2000, pp. 1292-1297
Authors:
Peters, WA
Liu, PY
Barrett, RJ
Stock, RJ
Monk, BJ
Berek, JS
Souhami, L
Grigsby, P
Gordon, W
Alberts, DS
Citation: Wa. Peters et al., Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix, J CL ONCOL, 18(8), 2000, pp. 1606-1613
Authors:
Monsky, WL
Heddens, DK
Clark, GM
Von Hoff, DD
Coltman, CA
Dorr, RT
Alberts, DS
Citation: Wl. Monsky et al., Comparison of young clinical investigators' accuracy and reproducibility when measuring pulmonary and skin surface nodules using a circumferential measurement versus a standard caliper measurement: American Association for Cancer Research/American Society of Clinical Oncology Clinical Trials Workshop, J CL ONCOL, 18(2), 2000, pp. 437-444
Authors:
Lopez, AM
Ketchum, M
Nichols, H
Xu, MJ
Peng, YM
Dorr, R
Alberts, DS
Citation: Am. Lopez et al., A phase I trial of AUC-directed carboplatin with infusional doxorubicin and ifosfamide plus G-CSF in patients with advanced gynecologic malignancies, CANC CHEMOT, 46(5), 2000, pp. 411-415
Authors:
Stratton, SP
Bangert, JL
Alberts, DS
Dorr, RT
Citation: Sp. Stratton et al., Dermal toxicity of topical (-)epigallocatechin-3-gallate in BALB/c and SKH1 mice, CANCER LETT, 158(1), 2000, pp. 47-52
Authors:
Dorr, RT
Dvorakova, K
Brooks, C
Lines, R
Levine, N
Schram, K
Miketova, P
Hruby, V
Alberts, DS
Citation: Rt. Dorr et al., Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle(4)-D-Phe(7)]-alpha-MSH in humans, PHOTOCHEM P, 72(4), 2000, pp. 526-532